Dr. Evie Carchman | Cancer prevention | Best Researcher Award
Associate Professor | University of Wisconsin | United States
1. Johnson, H. R., Dietmann, E. C., Praska, C. E., Dennison, K. L., McGregor, S. M., Suter, W., Leverson, G., Murtaza, M., & Carchman, E. H. (2025, November). Detection of PIK3CA mutations in anal dysplasia. Journal of Surgical Research. Advance online publication.
2. Hewitt, A. J., Freeman, M. J., Hayden, D. M., Carchman, E. H., Schweizer, M. L., & Sanger, C. B. (2025, November). Evaluation of anal cancer screening practices among a national cohort of veterans with HIV. Diseases of the Colon & Rectum. Advance online publication.
3. DeZeeuw, A. K., Bassetti, M. F., Carchman, E. H., Heise, C. P., Hayden, D., Lawson, E. H., Sanger, C. B., King, R., LoConte, N. K., Lubner, S. J., et al. (2024, September 3). Carboplatin and paclitaxel chemoradiation for localized anal cancer in patients not eligible for mitomycin and 5-fluorouracil. Cancers, 16(17), 3062.
Cited by: 1
4. Lozar, T., Wang, W., Gavrielatou, N., Christensen, L., Lambert, P. F., Harari, P. M., Rimm, D. L., Burtness, B., Grasic Kuhar, C., & Carchman, E. H. (2023, November 25). Emerging prognostic and predictive significance of stress keratin 17 in HPV-associated and non HPV-associated human cancers: A scoping review. Viruses, 15(12), 2320.
Cited by: 4
Dr. Evie H. Carchman’s pioneering research in colorectal and anal cancer prevention integrates molecular oncology, surgical innovation, and translational science to improve patient outcomes. Her work advances global cancer prevention strategies through early detection, precision medicine, and evidence-based clinical practice.